|
|
Volumn 290, Issue 5495, 2000, Pages 1280-1282
|
|
Planned ritalin trial for tots heads into uncharted waters
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METHYLPHENIDATE;
CENTRAL STIMULANT AGENT;
ATTENTION DEFICIT DISORDER;
CHILD;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INFORMED CONSENT;
MEDICAL ETHICS;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
ARTICLE;
BIOETHICS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
MENTAL HEALTH SERVICE;
PATIENT SELECTION;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BIOETHICS;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
INFORMED CONSENT;
METHYLPHENIDATE;
NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.);
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
|
|
EID: 0034680894
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5495.1280 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|